Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Johnston (Belfast (Belfast), United Kingdom), T. Ferguson (Belfast (Belfast), United Kingdom), K. Moffitt (Belfast (Belfast), United Kingdom), D. McCafferty (Belfast (Belfast), United Kingdom). An innovative high sensitivity tool for active neutrophil elastase quantification. 1141

Member's Comments

No comment yet.

Related content which might interest you: Investigating optimal sputum processing methods for active neutrophil elastase quantification Source: International Congress 2017 – Techniques in biomarker selection Year: 2017 The adaptation of a point of care test for the quantitative determination of active neutrophil elastase in sputum Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection Year: 2020 A novel point of care test for sputum sample stratification prior to the quantitative measurement of active neutrophil elastase Source: International Congress 2018 – Clinical and functional monitoring in airway disease Year: 2018 Neutrophil activity assessed using a novel serological marker of human neutrophil elastase degraded calprotectin is elevated in patients with COPD or IPF Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021 In vitro and in vivo characterisation of the novel neutrophil elastase inhibitor BI 1323495 Source: Virtual Congress 2020 – Scientific advances in airway pharmacology Year: 2020 The development of a novel immunoassay for the quantification of active tryptase Source: International Congress 2017 – Chronic airway disease: markers of disease impact Year: 2017 A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation Source: Eur Respir J, 53 (6) 1900303; 10.1183/13993003.00303-2019 Year: 2019 A rapid method to increase the clinical use of sputum inflammatory cells Source: International Congress 2017 – Techniques in biomarker selection Year: 2017 New method for rapid and dynamic quantification of elastase activity on sputum neutrophils from patients with cystic fibrosis using flow cytometry Source: Eur Respir J, 55 (4) 1902355; 10.1183/13993003.02355-2019 Year: 2020 PP102 – A serum biomarker reflecting human neutrophil elastase degraded calprotectin is elevated in COPD and IPF Source: ERS Lung Science Conference 2021 Year: 2021 Development of a novel immunoassay for the measurement of active plasmin in patients with IPF Source: International Congress 2017 – Chronic airway disease: markers of disease impact Year: 2017 Effects of a neutrophil elastase inhibitor against mediators of acute exacerbation of pulmonary fibrosis: a new therapeutic strategy Source: Annual Congress 2008 - New therapeutic strategies in idiopathic pulmonary fibrosis Year: 2008 Validation of an activity-based immunoassay for measurement of active cathepsin g in sputum Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection Year: 2020 A point of care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections Year: 2019 LSC Abstract – A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection Source: Lung Science Conference 2015 Year: 2015 Towards precision medicine in bronchiectasis: what is the role of neutrophilic elastase determination? Source: Eur Respir J, 53 (6) 1900765; 10.1183/13993003.00765-2019 Year: 2019 Treatment step-up strategy based on sputum eosinophil levels does not yield any better results than standard strategy Source: Eur Respir J 2005; 26: Suppl. 49, 574s Year: 2005 A phenotypic high-throughput screening assay for the pharmacological inhibition of the pathological deposition of extracellular matrix Source: ERS Lung Science Conference 2018 Year: 2018 Usefulness of the measurement of plasma neutrophil gelatinase-associated lipocalin as a biomarker for predicting prognosis in hospitalized patients with pneumonia Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018